Mar 24, 2020
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Mar 19, 2020
Glucagon Receptor Structures Reveal G protein Specificity Mechanism
Feb 11, 2020
Gifford Bioscience Launch New SPR (Biacore) Assay Service
Dec 17, 2019
Kanazawa University Research: Possible Strategy for Cancer Treatment Found in Nuclear Transport Proteins
Dec 17, 2019
Biohaven Achieves Positive Topline Results in Pivotal Phase 2/3 Study of Vazegepant, The First and Only Intranasal CGRP Receptor Antagonist in Clinical Development for the Acute Treatment of Migraine
Aug 27, 2019
AntlerA Leverages Precision-engineered Protein Therapeutic Platform to Harness Body's Regenerative Potential
Jul 11, 2019
Biohaven Showcases Positive Data on Rimegepant, Oral CGRP Receptor Antagonist, with 16 Presentations at 2019 American Headache Society (AHS) Annual Scientific Meeting Demonstrating Efficacy in Multiple Patient Types and Long-term Safety
Jul 01, 2019
The global EGFR inhibitors market at a CAGR of almost 9% during the forecast period
Jun 26, 2019
Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) Overview 2019: An Oral Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1), VEGFR-2, & VEGFR-3
Jun 17, 2019
Kanazawa University Research: Mapping and Measuring Proteins on the Surfaces of Endoplasmic Reticulum (ER) in Cells
Apr 17, 2019
Cell Signaling Technology Announces New Corporate Partners
Mar 30, 2019
Cell Press and Cell Signaling Technology Launch Online Resource to Help Scientists Achieve Experimental and Career Success
Mar 25, 2019
AlzeCure to Present at International Scientific Conference
Mar 14, 2019
Targovax Grants Zelluna Immunotherapy an FTO License to Intellectual Property Relating to Mutant Ras T Cell Receptor Technology
Feb 14, 2019
Addiction Medicine Practice Opens 8th Treatment Center in Northern Shenandoah Valley
Feb 04, 2019
Biohaven Achieves Targeted Therapeutic Exposures of BHV-3500, a Third-Generation Small Molecule CGRP Receptor Antagonist
Feb 01, 2019
Alkermes Receives Complete Response Letter From U.S. Food and Drug Administration for ALKS 5461 New Drug Application
Jan 28, 2019
Kanazawa University Research: Scientists Successfully Obtain Synthetic Growth Factor Compatible to the Native Protein
Jan 25, 2019
Aquestive Therapeutics Granted Temporary Restraining Order (TRO) Against Alvogen
Jan 14, 2019
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of epoCat(TM) for the Management of Non-Regenerative Anemia in Cats and Availability of Mirataz® at Banfield Pet Hospital